31NP
Crystal structure of the complex of galectin-8N-2,6-anhydro-3-deoxy-3-S-(beta-D-galactopyranosyl)-3-thio-D-glycero-L-altro-heptonamide
これはPDB形式変換不可エントリーです。
31NP の概要
| エントリーDOI | 10.2210/pdb31np/pdb |
| 関連するPDBエントリー | 31ML |
| 分子名称 | Galectin-8, GLYCEROL, 1-thio-beta-D-galactopyranose, ... (5 entities in total) |
| 機能のキーワード | galectin-8n, sugar binding protein |
| 由来する生物種 | Homo sapiens (human) |
| タンパク質・核酸の鎖数 | 1 |
| 化学式量合計 | 36441.64 |
| 構造登録者 | |
| 主引用文献 | Tsagkarakou, A.S.,Kantsadi, A.L.,Theodoridou, V.I.,Veliotis, N.,Lazar, L.,Jozsef, J.,Juhasz, L.,Kontopidis, G.,Leffler, H.,Nilsson, U.J.,Somsak, L.,Leonidas, D.D. Structural and Biophysical Characterization of C-Glycosylic 1,2-Thiodisaccharides Reveals Determinants of Selective Binding to Galectin-7 and Galectin-8N. Chemmedchem, 21:e70439-e70439, 2026 Cited by PubMed Abstract: Achieving isoform selectivity within the galectin family remains a central challenge in glycomimetic drug design due to the highly conserved architecture of their carbohydrate recognition domains. Here, we define the structural and thermodynamic basis of recognition of a series of C-glycosylic 1,2-thiodisaccharides targeting human galectin-7 and the N-terminal domain of galectin-8 (galectin-8N). Using an integrated approach combining fluorescence polarization, isothermal titration calorimetry, and high-resolution X-Ray crystallography, we establish a clear structure-activity relationship across the ligand series. Compound 17 emerges as the most potent galectin-8N ligand (K = 13 μM), outperforming thiodigalactoside, while compound 13 shows preferential binding to galectin-7, demonstrating tunable isoform bias. Structural analysis reveals a conserved anchoring mechanism in which the β-galactoside unit (Gly-1) drives affinity through a rigid hydrogen-bonding and π-stacking network, whereas the second sugar (Gly-2) modulates potency by adopting distinct orientations in galectin-specific extended binding sites. Notably, ligand binding converges on conserved motifs while leaving nonconserved regions unexploited, highlighting clear opportunities for structure-guided optimization. Collectively, this work establishes C-glycosylic thiodisaccharides as a robust platform for selective galectin targeting and provides actionable design principles for next-generation inhibitors. PubMed: 42603778DOI: 10.1002/cmdc.70439 主引用文献が同じPDBエントリー |
| 実験手法 | X-RAY DIFFRACTION (1.78 Å) |
構造検証レポート
検証レポート(詳細版)
をダウンロード






